216 related articles for article (PubMed ID: 28295628)
21. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
[TBL] [Abstract][Full Text] [Related]
22. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration.
Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G
Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
24. Ratio of baseline erythropoietin (EPO) level and corrected reticulocyte count as an indicator for a favourable response to recombinant human erythropoietin (rhEPO) therapy in anaemic cancer patients.
Charuruks N; Voravud N; Limpanasithikul W
J Clin Lab Anal; 2001; 15(5):260-6. PubMed ID: 11574955
[TBL] [Abstract][Full Text] [Related]
25. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
[TBL] [Abstract][Full Text] [Related]
26. Enhanced coagulation and fibrinolysis during treatment with recombinant human erythropoietin in patients undergoing chronic hemodialysis.
Tomura S; Nakamura Y; Tachibana K; Deguchi F; Ando R; Chida Y; Marumo F
Blood Purif; 1993; 11(6):370-7. PubMed ID: 8043258
[TBL] [Abstract][Full Text] [Related]
27. Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients.
do Sameiro-Faria M; Ribeiro S; Rocha-Pereira P; Fernandes J; Reis F; Bronze-da-Rocha E; Miranda V; Quintanilha A; Costa E; Belo L; Santos-Silva A
Ren Fail; 2013; 35(10):1392-8. PubMed ID: 23991655
[TBL] [Abstract][Full Text] [Related]
28. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy.
Costa E; Lima M; Alves JM; Rocha S; Rocha-Pereira P; Castro E; Miranda V; do SF; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Clin Immunol; 2008 May; 28(3):268-75. PubMed ID: 18205031
[TBL] [Abstract][Full Text] [Related]
29. Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis.
Németh I; Túri S; Haszon I; Bereczki C
Pediatr Nephrol; 2000 Jan; 14(1):13-7. PubMed ID: 10654322
[TBL] [Abstract][Full Text] [Related]
30. Effects of a vitamin E-bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients.
Usberti M; Gerardi G; Micheli A; Tira P; Bufano G; Gaggia P; Movilli E; Cancarini GC; De Marinis S; D'Avolio G; Broccoli R; Manganoni A; Albertin A; Di Lorenzo D
J Nephrol; 2002; 15(5):558-64. PubMed ID: 12455724
[TBL] [Abstract][Full Text] [Related]
31. [The effect of human recombinant erythropoietin on the lipid peroxidation processes and antioxidant protection of the erythrocytes in patients with chronic kidney failure on hemodialysis].
Rud'ko IA; Balashova TS; Pokrovskiĭ IuA; Ermolenko VM; Kubatiev AA
Gematol Transfuziol; 1993 Mar; 38(3):24-6. PubMed ID: 8020730
[TBL] [Abstract][Full Text] [Related]
32. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy.
Schaefer RM; Schaefer L
J Perinat Med; 1995; 23(1-2):83-8. PubMed ID: 7658326
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin resistance due to vitamin B12 deficiency. Case report and retrospective analysis of B12 levels after erythropoietin treatment.
Zachee P; Chew SL; Daelemans R; Lins RL
Am J Nephrol; 1992; 12(3):188-91. PubMed ID: 1415379
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of renal anemia with recombinant human erythropoietin].
Burghard R; Gordjani N; Leititis JU
Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
[TBL] [Abstract][Full Text] [Related]
35. Effects of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo.
Hino M; Miyazono K; Urabe A; Takaku F
Int J Cell Cloning; 1989 Jul; 7(4):257-63. PubMed ID: 2768843
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: analysis of 702 patients after 10-year follow-up.
Chang HC; Chen CL; Chiu TL; Chen SI; Yen AM; Chen TH
Public Health Nutr; 2009 Dec; 12(12):2410-5. PubMed ID: 19344540
[TBL] [Abstract][Full Text] [Related]
37. The prebiotic effects of soluble dietary fiber mixture on renal anemia and the gut microbiota in end-stage renal disease patients on maintenance hemodialysis: a prospective, randomized, placebo-controlled study.
Li Y; Han M; Song J; Liu S; Wang Y; Su X; Wei K; Xu Z; Li H; Wang Z
J Transl Med; 2022 Dec; 20(1):599. PubMed ID: 36517799
[TBL] [Abstract][Full Text] [Related]
38. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the efficacy of a biogeneric recombinant human erythropoietin alfa in the management of renal anemia in patients on hemodialysis: a multi-center clinical trial.
Beiraghdar F; Panahi Y; Einollahi B; Nemati E; Ghadiani MH; Sahebkar A; Maghsoudi N; Marzony ET
Clin Lab; 2012; 58(7-8):737-45. PubMed ID: 22997974
[TBL] [Abstract][Full Text] [Related]
40. [Assessment of iron requirements during treatment of anemia with recombinant human erythropoietin in patients with chronic renal insufficiency under hemodialysis].
Oliveira C; Boquinhas H; Gaspar A; Adragão T; Boquinhas JM; Júnior EC; Simões J
Acta Med Port; 1992 Jul; 5(7):351-7. PubMed ID: 1442178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
